This is a Validated Antibody Database (VAD) review about mouse Cldn2, based on 56 published articles (read how Labome selects the articles), using Cldn2 antibody in all methods. It is aimed to help Labome visitors find the most suited Cldn2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cldn2 synonym: AL022813

Knockout validation
Invitrogen
mouse monoclonal (12H12)
  • western blot knockout validation; human; 1:5000; loading ...; fig 2a
  • immunohistochemistry; human; 1:250; loading ...; fig 3a, 5d, s1
Invitrogen Cldn2 antibody (Thermofisher, 325600) was used in western blot knockout validation on human samples at 1:5000 (fig 2a) and in immunohistochemistry on human samples at 1:250 (fig 3a, 5d, s1). Commun Biol (2021) ncbi
Invitrogen
mouse monoclonal (12H12)
  • western blot knockout validation; human; 1:5000; loading ...; fig 2a
  • immunohistochemistry; human; 1:250; loading ...; fig 3a, 5d, s1
Invitrogen Cldn2 antibody (Thermofisher, 325600) was used in western blot knockout validation on human samples at 1:5000 (fig 2a) and in immunohistochemistry on human samples at 1:250 (fig 3a, 5d, s1). Commun Biol (2021) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1d
  • immunocytochemistry; human; loading ...; fig 3l, 5b
  • western blot; human; loading ...; fig 4i
  • immunoprecipitation; dogs; loading ...; fig 6a
  • immunocytochemistry; dogs; loading ...; fig 3b
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2c
  • western blot; mouse; loading ...; fig 2b
Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in immunohistochemistry - paraffin section on human samples (fig 1d), in immunocytochemistry on human samples (fig 3l, 5b), in western blot on human samples (fig 4i), in immunoprecipitation on dogs samples (fig 6a), in immunocytochemistry on dogs samples (fig 3b), in immunohistochemistry - paraffin section on mouse samples (fig 2c) and in western blot on mouse samples (fig 2b). J Exp Clin Cancer Res (2021) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; dogs; fig 2
  • western blot; dogs; fig 2
In order to study the role of claudin-4 in tight junctions in MDCK cells, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in immunocytochemistry on dogs samples (fig 2) and in western blot on dogs samples (fig 2). PLoS ONE (2017) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - paraffin section; dogs; 1:200; loading ...; fig 2b
  • western blot; dogs; 1:1000; loading ...; fig 1f
In order to measure tight junction protein expression in canine duodenum, lung, liver, and kidney, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in immunohistochemistry - paraffin section on dogs samples at 1:200 (fig 2b) and in western blot on dogs samples at 1:1000 (fig 1f). Mol Med Rep (2016) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - paraffin section; human; fig 4E
  • immunocytochemistry; human; fig 2E
  • western blot; human; fig 1
In order to establish methods to assess claudin-2 expression and localization in human colon biopsy samples, Invitrogen Cldn2 antibody (Invitrogen, 32?C5600) was used in immunohistochemistry - paraffin section on human samples (fig 4E), in immunocytochemistry on human samples (fig 2E) and in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry; mouse; 7 ug/ml; loading ...; tbl s5
  • western blot; mouse; 3 ug/ml; loading ...; tbl s5
In order to explore the effects of mild chronic psychological stress on metabolic, inflammatory, and behavioral profiles in a mouse model of diet-induced obesity, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in immunohistochemistry on mouse samples at 7 ug/ml (tbl s5) and in western blot on mouse samples at 3 ug/ml (tbl s5). Brain Behav Immun (2017) ncbi
mouse monoclonal (12H12)
  • western blot; mouse; 1:1000; loading ...; fig 3a
In order to evaluate the effect of glucocorticoids in a mouse model of colitis, Invitrogen Cldn2 antibody (Thermo Fisher, 32-5600) was used in western blot on mouse samples at 1:1000 (fig 3a). Biochem Pharmacol (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 3
In order to study attenuation of oxazolone-induced colitis in mice through suppression of inflammataion and epithelial barrier disruption via modified pulsatilla decoction, Invitrogen Cldn2 antibody (Invitrogen, PA5-13335) was used in western blot on mouse samples at 1:1000 (fig 3). Mol Med Rep (2016) ncbi
mouse monoclonal (12H12)
  • western blot; rhesus macaque; 2 ug/ml; loading ...; fig 9b
In order to study a nonhuman primate model of chronic gastrointestinal syndrome, Invitrogen Cldn2 antibody (Invitrogen, 325600) was used in western blot on rhesus macaque samples at 2 ug/ml (fig 9b). Radiat Res (2016) ncbi
mouse monoclonal (12H12)
  • western blot; domestic goat; 1:1000; fig 3
In order to characterize a reduced N and/or Ca diet by expression of tight junction proteins and cadherin 17 in the small intestine of young goats, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in western blot on domestic goat samples at 1:1000 (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - paraffin section; mouse; fig 1
In order to utilize a microwave antigen retrieval method by using two heating steps for enhanced immunostaining on tissue sections that are aldehyde-fixed and paraffin-embedded, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Histochem Cell Biol (2016) ncbi
mouse monoclonal (12H12)
  • western blot; human
In order to study OGR1-mediated, pH-dependent signaling pathways in intestinal epithelial cells, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in western blot on human samples . Am J Physiol Gastrointest Liver Physiol (2015) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; dogs; fig 3g
  • western blot; dogs; fig 3f
In order to investigate the interaction between ZO-1 and TOCA-1, Invitrogen Cldn2 antibody (Life Technologies, 32-5600) was used in immunocytochemistry on dogs samples (fig 3g) and in western blot on dogs samples (fig 3f). Mol Biol Cell (2015) ncbi
mouse monoclonal (12H12)
  • western blot; human; 0.1 ug/ml; fig 1
  • western blot; mouse; 0.1 ug/ml; fig 1
In order to analyze breast cancer liver metastasis and how Lyn modulates Claudin-2 expression as a therapeutic target, Invitrogen Cldn2 antibody (Invitrogen, 325600) was used in western blot on human samples at 0.1 ug/ml (fig 1) and in western blot on mouse samples at 0.1 ug/ml (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry; rat; 1:2000; fig 9
In order to examine the mast cell proteinase and tight junction protein kinetics in a rat model of post-infectious gut dysfunction, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in immunohistochemistry on rat samples at 1:2000 (fig 9). J Crohns Colitis (2015) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; dogs
  • western blot; dogs
In order to characterize TALEN-mediated claudin-2 knockout in MDCK cells, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in immunocytochemistry on dogs samples and in western blot on dogs samples . PLoS ONE (2015) ncbi
mouse monoclonal (12H12)
  • western blot; human
In order to investigate the effect of homoharringtonine on intestinal epithelial permeability and its mechanism, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in western blot on human samples . Eur J Pharm Biopharm (2015) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry; human; 1:100; fig 1
In order to correlate expression of claudins with clinical outcomes of triple-negative breast cancer, Invitrogen Cldn2 antibody (Zymed, 12H12) was used in immunohistochemistry on human samples at 1:100 (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (12H12)
  • flow cytometry; human
In order to perform longitudinal and cross-sectional studies of patients after restorative proctocolectomy and assess tight junction proteins and dendritic cell characteristics in the ileal pouch, Invitrogen Cldn2 antibody (Invitrogen, 12H12) was used in flow cytometry on human samples . Inflamm Bowel Dis (2014) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; dogs
  • western blot; dogs
In order to characterize the TALEN-mediated ZO-1 knockout in MDCK cells, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in immunocytochemistry on dogs samples and in western blot on dogs samples . PLoS ONE (2014) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; human; fig 3
In order to assess the role of Toll-like receptor 2 in maintaining the integrity of the airway epithelial barrier, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in immunocytochemistry on human samples (fig 3). Tissue Barriers (2014) ncbi
mouse monoclonal (12H12)
  • western blot; human
In order to investigate the localization of POF1B in desmosomes and its role in human intestinal and keratinocyte cell lines, Invitrogen Cldn2 antibody (Zymed Laboratories, 32-5600) was used in western blot on human samples . J Invest Dermatol (2015) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1b
In order to correlate claudin 1-5 and 7 expression with the survival, grade, and stage of patients with renal cell cancer, Invitrogen Cldn2 antibody (Zymed, 12H12) was used in immunohistochemistry - paraffin section on human samples (fig 1b). Anticancer Res (2014) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; human; 1:100; fig 4
In order to assess the contribution of enteropathogenic Escherichia coli EspG-mediated microtubule disruption to tight junction perturbation, Invitrogen Cldn2 antibody (Life Technologies, 325600) was used in immunocytochemistry on human samples at 1:100 (fig 4). Cell Microbiol (2014) ncbi
mouse monoclonal (12H12)
  • western blot; mouse; loading ...; fig 6b
In order to study the role of TH9 cells in ulcerative colitis, Invitrogen Cldn2 antibody (Invitrogen, 12H12) was used in western blot on mouse samples (fig 6b). Nat Immunol (2014) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; human; 1:300
  • western blot; human; 1:500
In order to evaluate claudin 2 as a proximal tubular stress responsive paracellular water channel, Invitrogen Cldn2 antibody (Zymed, 32-5600) was used in immunocytochemistry on human samples at 1:300 and in western blot on human samples at 1:500. Toxicol Appl Pharmacol (2014) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry; human
  • western blot; human; 1:5000
In order to study the involvement of TJP2 mautations in progressive cholestatic liver disease, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in immunohistochemistry on human samples and in western blot on human samples at 1:5000. Nat Genet (2014) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; human; fig 3
  • western blot; human; 0.8 ug/ml; fig 3
In order to study the molecular processes involved in renal epithelial proximal-tubule monolayer maturation, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples at 0.8 ug/ml (fig 3). Mol Cell Biol (2013) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - frozen section; mouse; 2.5 ug/ml; fig 4
  • western blot; mouse
  • immunohistochemistry - paraffin section; human
In order to study the effects of intestinal barrier proteins in necrotizing enterocolitis and test if Bifidobacterium infantis modulates tight junction proteins, Invitrogen Cldn2 antibody (Life Technologies, 32-5600) was used in immunohistochemistry - frozen section on mouse samples at 2.5 ug/ml (fig 4), in western blot on mouse samples and in immunohistochemistry - paraffin section on human samples . Am J Pathol (2013) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - frozen section; mouse; fig 3
In order to examine innate responses to Entamoeba histolytica in wild-type and MUC-2-deficient mice, Invitrogen Cldn2 antibody (Invitrogen, 325600) was used in immunohistochemistry - frozen section on mouse samples (fig 3). Am J Pathol (2013) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to examine tight junction and adherens junction proteins in normal human lung, IPF, cryptogenic organizing pneumonia, and asbestosis, Invitrogen Cldn2 antibody (Zymed, 12H12) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Hum Pathol (2013) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - frozen section; human; 1:100; fig 2
  • western blot; human; fig 2
In order to identify genetic variants associated with pancreatitis, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 2) and in western blot on human samples (fig 2). Nat Genet (2012) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - frozen section; mouse; 1:250; fig 4
  • immunoprecipitation; mouse; fig 2
  • western blot; mouse; 1:500; fig 2
In order to report that mice lacking EpCAM have intestinal barrier defects and die shortly after birth as a result of intestinal erosion, Invitrogen Cldn2 antibody (Zymed, 32-5600) was used in immunohistochemistry - frozen section on mouse samples at 1:250 (fig 4), in immunoprecipitation on mouse samples (fig 2) and in western blot on mouse samples at 1:500 (fig 2). Dev Biol (2012) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; human; 1:300; fig 4
  • western blot; human; 1:600; fig 6
In order to determine the effects of KBrO(3) using human and rat proximal tubular cell lines, Invitrogen Cldn2 antibody (Zymed, 32-5600) was used in immunocytochemistry on human samples at 1:300 (fig 4) and in western blot on human samples at 1:600 (fig 6). Arch Toxicol (2012) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - frozen section; human; 1:100
  • western blot; human; 1:1000; fig 2
In order to assess the role of tight junctions and gap proteins in cervical remodeling, Invitrogen Cldn2 antibody (Zymed, 32-5600) was used in immunohistochemistry - frozen section on human samples at 1:100 and in western blot on human samples at 1:1000 (fig 2). J Transl Med (2012) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; dogs; fig 1
  • western blot; dogs; fig 2, 4
In order to examine the effect of treating epithelial cells with an inhibitor of the lipid kinase PIKfyve, Invitrogen Cldn2 antibody (Zymed, 32-5600) was used in immunocytochemistry on dogs samples (fig 1) and in western blot on dogs samples (fig 2, 4). PLoS ONE (2012) ncbi
mouse monoclonal (12H12)
  • western blot; dogs; fig 1
In order to analyze the role of paracingulin domains, Invitrogen Cldn2 antibody (Invitrogen, 32-5600) was used in western blot on dogs samples (fig 1). J Biol Chem (2012) ncbi
mouse monoclonal (12H12)
  • flow cytometry; mouse; fig 3
  • western blot; mouse; fig s1
In order to identify Cldn1, Cldn2 and Cldn11 as genes that discriminate between diverse types of M2, Invitrogen Cldn2 antibody (Invitrogen, 12H12) was used in flow cytometry on mouse samples (fig 3) and in western blot on mouse samples (fig s1). Scand J Immunol (2012) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; dogs; 1:25; fig s7
In order to demonstrate that ESCRT proteins are required to maintain polarity in mammalian epithelial cells, Invitrogen Cldn2 antibody (Zymed, 32-5600) was used in immunocytochemistry on dogs samples at 1:25 (fig s7). Mol Biol Cell (2011) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - paraffin section; human; fig 3
In order to determine claudin expression profiles in Epstein-Barr virus-associated non-keratinizing nasopharyngeal carcinoma, Invitrogen Cldn2 antibody (Zymed, 12H12) was used in immunohistochemistry - paraffin section on human samples (fig 3). Oncol Rep (2010) ncbi
mouse monoclonal (12H12)
  • western blot; mouse; 1:100; fig 10
In order to examine the consequences of HNF-4alpha loss in the adult intestinal epithelium, Invitrogen Cldn2 antibody (Zymed, 32-5600) was used in western blot on mouse samples at 1:100 (fig 10). Mol Cell Biol (2009) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; rat; 1:100; tbl 3
In order to study the role of claudin-2 in bile canalicular formation, Invitrogen Cldn2 antibody (Zymed, 12H12) was used in immunocytochemistry on rat samples at 1:100 (tbl 3). Histochem Cell Biol (2009) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
In order to determine the expression of several different claudins in rectal well-differentiated endocrine neoplasms, Invitrogen Cldn2 antibody (Zymed, 12H12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Oncol Rep (2009) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1b
In order to report the expression of various claudins in patients with sarcoidosis, usual interstitial pneumonia, and normal human lung, Invitrogen Cldn2 antibody (Zymed, 12H12) was used in immunohistochemistry - paraffin section on human samples (fig 1b). J Histochem Cytochem (2009) ncbi
mouse monoclonal (12H12)
  • western blot; human; fig 1
In order to elucidate how the keratin intermediate filament network is involved in the establishment and maintenance of cell polarity, Invitrogen Cldn2 antibody (Invitrogen, 12H12) was used in western blot on human samples (fig 1). J Cell Biol (2008) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - paraffin section; human; fig 1
In order to test if altered expression of intestinal epithelial tight junction proteins contributes to neoplastic progression, Invitrogen Cldn2 antibody (Invitrogen, 12H12) was used in immunohistochemistry - paraffin section on human samples (fig 1). Lab Invest (2008) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - paraffin section; human; 1:100; fig 3
In order to study the role of CLDN2 expression in breast cancer development and progression, Invitrogen Cldn2 antibody (Zymed, 12H12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3). Histopathology (2008) ncbi
mouse monoclonal (12H12)
  • western blot; dogs; fig 3
In order to study the effects of cingulin overexpression, Invitrogen Cldn2 antibody (Zymed, 32-5600) was used in western blot on dogs samples (fig 3). Mol Membr Biol (2008) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; rat; 1:100; fig 2B
In order to determine whether transforming growth factor-beta down-regulates claudin-1 expression to induce epithelial to mesenchymal transition, Invitrogen Cldn2 antibody (Zymed, 12H12) was used in immunocytochemistry on rat samples at 1:100 (fig 2B). Liver Int (2008) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - paraffin section; human; 1:400; fig 4
In order to correlate glutamine synthetase immunostaining and beta-catenin mutations with clinicopathological features in hepatocellular carcinomas, Invitrogen Cldn2 antibody (Zymed, clone 12H12) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 4). J Pathol (2007) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; dogs; fig 4
  • western blot; dogs; fig 1
In order to investigate the function of cingulin in tight junctions, Invitrogen Cldn2 antibody (Zymed, 32-5600) was used in immunocytochemistry on dogs samples (fig 4) and in western blot on dogs samples (fig 1). Mol Biol Cell (2006) ncbi
mouse monoclonal (12H12)
  • immunohistochemistry - paraffin section; human; 1:50
In order to observe the expression of claudins in mesothelioma and metastatic pleural adenocarcinoma, Invitrogen Cldn2 antibody (Zymed, 12H12) was used in immunohistochemistry - paraffin section on human samples at 1:50. J Clin Pathol (2006) ncbi
mouse monoclonal (12H12)
  • immunocytochemistry; rat
  • immunocytochemistry; American opossums
  • immunocytochemistry; pigs
  • immunocytochemistry; human
In order to characterize cell lines that mimic the characteristics of the proximal tubule, Invitrogen Cldn2 antibody (Zymed, 32-5600) was used in immunocytochemistry on rat samples , in immunocytochemistry on American opossums samples , in immunocytochemistry on pigs samples and in immunocytochemistry on human samples . Toxicol In Vitro (2006) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:1000; loading ...; fig s3a
Abcam Cldn2 antibody (Abcam, ab53032) was used in immunohistochemistry on mouse samples at 1:1000 (fig s3a). Redox Biol (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig s2c
  • western blot; mouse; 1:500; loading ...; fig s2a
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2c
  • western blot; human; 1:500; loading ...; fig 2a
Abcam Cldn2 antibody (Abcam, ab53032) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig s2c), in western blot on mouse samples at 1:500 (fig s2a), in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2c) and in western blot on human samples at 1:500 (fig 2a). MBio (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; loading ...; fig 2d
Abcam Cldn2 antibody (Abcam, ab53032) was used in immunohistochemistry on mouse samples at 1:200 (fig 2d). Cell Mol Gastroenterol Hepatol (2019) ncbi
Articles Reviewed
  1. Tabariès S, Annis M, Lazaris A, Petrillo S, Huxham J, Abdellatif A, et al. Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern. Commun Biol. 2021;4:657 pubmed publisher
  2. Liu M, Rao H, Liu J, Li X, Feng W, Gui L, et al. The histone methyltransferase SETD2 modulates oxidative stress to attenuate experimental colitis. Redox Biol. 2021;43:102004 pubmed publisher
  3. Kumar B, Ahmad R, Giannico G, Zent R, Talmon G, Harris R, et al. Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation. J Exp Clin Cancer Res. 2021;40:77 pubmed publisher
  4. Sepe L, Hartl K, Iftekhar A, Berger H, Kumar N, Goosmann C, et al. Genotoxic Effect of Salmonella Paratyphi A Infection on Human Primary Gallbladder Cells. MBio. 2020;11: pubmed publisher
  5. Kiyohara H, Sujino T, Teratani T, Miyamoto K, Arai M, Nomura E, et al. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells. Cell Mol Gastroenterol Hepatol. 2019;7:135-156 pubmed publisher
  6. Tokuda S, Hirai T, Furuse M. Claudin-4 knockout by TALEN-mediated gene targeting in MDCK cells: Claudin-4 is dispensable for the permeability properties of tight junctions in wild-type MDCK cells. PLoS ONE. 2017;12:e0182521 pubmed publisher
  7. Ahn C, Shin D, Lee D, Kang S, Seok J, Kang H, et al. Expression of claudins, occludin, junction adhesion molecule A and zona occludens 1 in canine organs. Mol Med Rep. 2016;14:3697-703 pubmed publisher
  8. Randall K, Henderson N, Reens J, Eckersley S, Nyström A, South M, et al. Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies. PLoS ONE. 2016;11:e0162076 pubmed publisher
  9. de Sousa Rodrigues M, Bekhbat M, Houser M, Chang J, Walker D, Jones D, et al. Chronic psychological stress and high-fat high-fructose diet disrupt metabolic and inflammatory gene networks in the brain, liver, and gut and promote behavioral deficits in mice. Brain Behav Immun. 2017;59:158-172 pubmed publisher
  10. Ocón B, Aranda C, Gámez Belmonte R, Suárez M, Zarzuelo A, Martinez Augustin O, et al. The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice. Biochem Pharmacol. 2016;116:73-88 pubmed publisher
  11. Wang X, Fan F, Cao Q. Modified Pulsatilla decoction attenuates oxazolone-induced colitis in mice through suppression of inflammation and epithelial barrier disruption. Mol Med Rep. 2016;14:1173-9 pubmed publisher
  12. Shea Donohue T, Fasano A, Zhao A, Notari L, Yan S, Sun R, et al. Mechanisms Involved in the Development of the Chronic Gastrointestinal Syndrome in Nonhuman Primates after Total-Body Irradiation with Bone Marrow Shielding. Radiat Res. 2016;185:591-603 pubmed publisher
  13. Elfers K, Marr I, Wilkens M, Breves G, Langeheine M, Brehm R, et al. Expression of Tight Junction Proteins and Cadherin 17 in the Small Intestine of Young Goats Offered a Reduced N and/or Ca Diet. PLoS ONE. 2016;11:e0154311 pubmed publisher
  14. Gu L, Cong J, Zhang J, Tian Y, Zhai X. A microwave antigen retrieval method using two heating steps for enhanced immunostaining on aldehyde-fixed paraffin-embedded tissue sections. Histochem Cell Biol. 2016;145:675-80 pubmed publisher
  15. de Vallière C, Vidal S, Clay I, Jurisic G, Tcymbarevich I, Lang S, et al. The pH-sensing receptor OGR1 improves barrier function of epithelial cells and inhibits migration in an acidic environment. Am J Physiol Gastrointest Liver Physiol. 2015;309:G475-90 pubmed publisher
  16. Van Itallie C, Tietgens A, Krystofiak E, Kachar B, Anderson J. A complex of ZO-1 and the BAR-domain protein TOCA-1 regulates actin assembly at the tight junction. Mol Biol Cell. 2015;26:2769-87 pubmed publisher
  17. Tabariès S, Annis M, Hsu B, Tam C, Savage P, Park M, et al. Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis. Oncotarget. 2015;6:9476-87 pubmed
  18. Fernández Blanco J, Estévez J, Shea Donohue T, Martínez V, Vergara P. Changes in Epithelial Barrier Function in Response to Parasitic Infection: Implications for IBD Pathogenesis. J Crohns Colitis. 2015;9:463-76 pubmed publisher
  19. Tokuda S, Furuse M. Claudin-2 knockout by TALEN-mediated gene targeting in MDCK cells: claudin-2 independently determines the leaky property of tight junctions in MDCK cells. PLoS ONE. 2015;10:e0119869 pubmed publisher
  20. Watari A, Hashegawa M, Yagi K, Kondoh M. Homoharringtonine increases intestinal epithelial permeability by modulating specific claudin isoforms in Caco-2 cell monolayers. Eur J Pharm Biopharm. 2015;89:232-8 pubmed publisher
  21. Ma F, Ding X, Fan Y, Ying J, Zheng S, Lu N, et al. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer. PLoS ONE. 2014;9:e112765 pubmed publisher
  22. Landy J, Al Hassi H, Ronde E, English N, Mann E, Bernardo D, et al. Innate immune factors in the development and maintenance of pouchitis. Inflamm Bowel Dis. 2014;20:1942-9 pubmed publisher
  23. Tokuda S, Higashi T, Furuse M. ZO-1 knockout by TALEN-mediated gene targeting in MDCK cells: involvement of ZO-1 in the regulation of cytoskeleton and cell shape. PLoS ONE. 2014;9:e104994 pubmed publisher
  24. Ragupathy S, Esmaeili F, Paschoud S, Sublet E, Citi S, Borchard G. Toll-like receptor 2 regulates the barrier function of human bronchial epithelial monolayers through atypical protein kinase C zeta, and an increase in expression of claudin-1. Tissue Barriers. 2014;2:e29166 pubmed publisher
  25. Crespi A, Bertoni A, Ferrari I, Padovano V, Della Mina P, Berti E, et al. POF1B localizes to desmosomes and regulates cell adhesion in human intestinal and keratinocyte cell lines. J Invest Dermatol. 2015;135:192-201 pubmed publisher
  26. Virman J, Soini Y, Kujala P, Luukkaala T, Salminen T, Sunela K, et al. Claudins as prognostic factors for renal cell cancer. Anticancer Res. 2014;34:4181-7 pubmed
  27. Glotfelty L, Zahs A, Hodges K, Shan K, Alto N, Hecht G. Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration. Cell Microbiol. 2014;16:1767-83 pubmed publisher
  28. Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H, Steiner S, et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol. 2014;15:676-86 pubmed publisher
  29. Wilmes A, Aschauer L, Limonciel A, Pfaller W, Jennings P. Evidence for a role of claudin 2 as a proximal tubular stress responsive paracellular water channel. Toxicol Appl Pharmacol. 2014;279:163-72 pubmed publisher
  30. Sambrotta M, Strautnieks S, Papouli E, Rushton P, Clark B, Parry D, et al. Mutations in TJP2 cause progressive cholestatic liver disease. Nat Genet. 2014;46:326-8 pubmed publisher
  31. Aschauer L, Gruber L, Pfaller W, Limonciel A, Athersuch T, Cavill R, et al. Delineation of the key aspects in the regulation of epithelial monolayer formation. Mol Cell Biol. 2013;33:2535-50 pubmed publisher
  32. Bergmann K, Liu S, Tian R, Kushnir A, Turner J, Li H, et al. Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis. Am J Pathol. 2013;182:1595-606 pubmed publisher
  33. Kissoon Singh V, Moreau F, Trusevych E, Chadee K. Entamoeba histolytica exacerbates epithelial tight junction permeability and proinflammatory responses in Muc2(-/-) mice. Am J Pathol. 2013;182:852-65 pubmed publisher
  34. Lappi Blanco E, Lehtonen S, Sormunen R, Merikallio H, Soini Y, Kaarteenaho R. Divergence of tight and adherens junction factors in alveolar epithelium in pulmonary fibrosis. Hum Pathol. 2013;44:895-907 pubmed publisher
  35. Whitcomb D, Larusch J, Krasinskas A, Klei L, Smith J, Brand R, et al. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet. 2012;44:1349-54 pubmed publisher
  36. Lei Z, Maeda T, Tamura A, Nakamura T, Yamazaki Y, Shiratori H, et al. EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins. Dev Biol. 2012;371:136-45 pubmed publisher
  37. Limonciel A, Wilmes A, Aschauer L, Radford R, Bloch K, McMorrow T, et al. Oxidative stress induced by potassium bromate exposure results in altered tight junction protein expression in renal proximal tubule cells. Arch Toxicol. 2012;86:1741-51 pubmed publisher
  38. Ghule V, Gray C, Galimberti A, Anumba D. Prostaglandin-induced cervical remodelling in humans in the first trimester is associated with increased expression of specific tight junction, but not gap junction proteins. J Transl Med. 2012;10:40 pubmed publisher
  39. Dukes J, Whitley P, Chalmers A. The PIKfyve inhibitor YM201636 blocks the continuous recycling of the tight junction proteins claudin-1 and claudin-2 in MDCK cells. PLoS ONE. 2012;7:e28659 pubmed publisher
  40. Paschoud S, Guillemot L, Citi S. Distinct domains of paracingulin are involved in its targeting to the actin cytoskeleton and regulation of apical junction assembly. J Biol Chem. 2012;287:13159-69 pubmed publisher
  41. Van den Bossche J, Laoui D, Morias Y, Movahedi K, Raes G, De Baetselier P, et al. Claudin-1, claudin-2 and claudin-11 genes differentially associate with distinct types of anti-inflammatory macrophages in vitro and with parasite- and tumour-elicited macrophages in vivo. Scand J Immunol. 2012;75:588-98 pubmed publisher
  42. Dukes J, Fish L, Richardson J, Blaikley E, Burns S, Caunt C, et al. Functional ESCRT machinery is required for constitutive recycling of claudin-1 and maintenance of polarity in vertebrate epithelial cells. Mol Biol Cell. 2011;22:3192-205 pubmed publisher
  43. Kojima F, Ishida M, Takikita Suzuki M, Hotta M, Katsura K, Nagata A, et al. Claudin expression profiles in Epstein-Barr virus-associated nasopharyngeal carcinoma. Oncol Rep. 2010;23:927-31 pubmed
  44. Cattin A, Le Beyec J, Barreau F, Saint Just S, Houllier A, Gonzalez F, et al. Hepatocyte nuclear factor 4alpha, a key factor for homeostasis, cell architecture, and barrier function of the adult intestinal epithelium. Mol Cell Biol. 2009;29:6294-308 pubmed publisher
  45. Son S, Kojima T, Decaens C, Yamaguchi H, Ito T, Imamura M, et al. Knockdown of tight junction protein claudin-2 prevents bile canalicular formation in WIF-B9 cells. Histochem Cell Biol. 2009;131:411-24 pubmed publisher
  46. Ishida M, Kushima R, Okabe H. Claudin expression in rectal well-differentiated endocrine neoplasms (carcinoid tumors). Oncol Rep. 2009;21:113-7 pubmed
  47. Kaarteenaho Wiik R, Soini Y. Claudin-1, -2, -3, -4, -5, and -7 in usual interstitial pneumonia and sarcoidosis. J Histochem Cytochem. 2009;57:187-95 pubmed publisher
  48. Sugimoto M, Inoko A, Shiromizu T, Nakayama M, Zou P, Yonemura S, et al. The keratin-binding protein Albatross regulates polarization of epithelial cells. J Cell Biol. 2008;183:19-28 pubmed publisher
  49. Weber C, Nalle S, Tretiakova M, Rubin D, Turner J. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 2008;88:1110-20 pubmed publisher
  50. Kim T, Huh J, Lee S, Kang H, Kim G, An H. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease. Histopathology. 2008;53:48-55 pubmed publisher
  51. Paschoud S, Citi S. Inducible overexpression of cingulin in stably transfected MDCK cells does not affect tight junction organization and gene expression. Mol Membr Biol. 2008;25:1-13 pubmed
  52. Kojima T, Takano K, Yamamoto T, Murata M, Son S, Imamura M, et al. Transforming growth factor-beta induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes. Liver Int. 2008;28:534-45 pubmed
  53. Audard V, Grimber G, Elie C, Radenen B, Audebourg A, Letourneur F, et al. Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations. J Pathol. 2007;212:345-52 pubmed
  54. Guillemot L, Citi S. Cingulin regulates claudin-2 expression and cell proliferation through the small GTPase RhoA. Mol Biol Cell. 2006;17:3569-77 pubmed
  55. Soini Y, Kinnula V, Kahlos K, Paakko P. Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura. J Clin Pathol. 2006;59:250-4 pubmed
  56. Prozialeck W, Edwards J, Lamar P, Smith C. Epithelial barrier characteristics and expression of cell adhesion molecules in proximal tubule-derived cell lines commonly used for in vitro toxicity studies. Toxicol In Vitro. 2006;20:942-53 pubmed